Organization

ACME MARKETS INC

According to 2025 Medicare claims, ACME MARKETS INC (NPI: 1558452185) practices centralized flu in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is ACME MARKETS INC (NPI: 1558452185) and primary practice location at 19063-9998.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 38,032 traditional Medicare patients, billed 127,745 HCPCS/CPT codes, and received $10,248,544 in Medicare payments. The top billing code was 91322 (Sarscov2 vac 50 mcg/0.5ml im). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,166,305 to $10,248,544. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	10,919	26,596	$1,166,305
2016	13,467	31,358	$1,344,518
2017	13,324	30,078	$1,258,278
2018	15,947	35,469	$1,465,635
2019	15,380	33,650	$1,357,269
2020	24,133	52,042	$2,246,089
2021	74,033	124,531	$5,293,858
2022	59,997	343,503	$8,102,731
2023	46,738	233,974	$9,530,351
2024	38,032	127,745	$10,248,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
91322	Sarscov2 vac 50 mcg/0.5ml im	9,622	10,950	$154
91320	Sarscv2 vac 30mcg trs-suc im	17,434	19,706	$148
90662	Influenza vaccine split virus, preservative free	27,360	27,445	$82
90480	Admn sarscov2 vacc 1 dose	26,429	30,669	$44
G0008	Administration of influenza virus vaccine	30,620	30,875	$34

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for ACME MARKETS INC?

Tedicare shows public-source Medicare data for ACME MARKETS INC (NPI 1558452185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does ACME MARKETS INC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to ACME MARKETS INC?

ACME MARKETS INC is linked to ACME MARKETS INC (billing NPI 1558452185) in the available physician profile data.

Does ACME MARKETS INC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.